ReviewFrontiers in psychiatry2026
RITA-T (rapid interactive screening test for autism in toddlers): a scoping review of psychometric properties, cross-cultural validation, and clinical applications.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Rapid Interactive Screening Test for Autism in Toddlers (RITA-T) is a clinician-administered, interactive screening instrument for toddlers aged 18-36 months that directly assesses core social-communicative abilities through structured play. Since its introduction in 2015, validation studies have emerged across diverse populations and cultural contexts. Objective: This scoping review systematically maps the evidence on RITA-T's development, psychometric properties, cross-cultural validation, clinical applications, and comparison with other level 2 screening instruments. Methods: A systematic search of PubMed, Web of Science, Scopus, PsycINFO, and CNKI was conducted through June 2026. Studies reporting original data on RITA-T administration in toddlers aged 18-36 months were included. Methodological quality was assessed using the QUADAS-2 tool. Results: Of 48 records identified, 10 original studies met the inclusion criteria: 7 diagnostic validation studies encompassing 659 toddlers across five countries (United States, Canada, Lebanon, Turkey, and China) and 3 implementation or training studies. RITA-T yielded strong psychometric properties across settings, with reported cutoff scores of 14-17, sensitivity of 0.74-1.00, and specificity of 0.50-1.00. Cross-cultural adaptations demonstrated comparable diagnostic accuracy across English, Arabic, Turkish, and Chinese versions. Conclusions: RITA-T represents an effective level 2 ASD screening tool with robust cross-cultural applicability. Future research should address long-term predictive validity, telehealth adaptation, and cost-effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.